1. Home
  2. KREF vs MNMD Comparison

KREF vs MNMD Comparison

Compare KREF & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KREF
  • MNMD
  • Stock Information
  • Founded
  • KREF 2014
  • MNMD 2019
  • Country
  • KREF United States
  • MNMD United States
  • Employees
  • KREF N/A
  • MNMD N/A
  • Industry
  • KREF Real Estate Investment Trusts
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • KREF Real Estate
  • MNMD Health Care
  • Exchange
  • KREF Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • KREF 701.3M
  • MNMD 672.1M
  • IPO Year
  • KREF 2017
  • MNMD N/A
  • Fundamental
  • Price
  • KREF $11.02
  • MNMD $7.63
  • Analyst Decision
  • KREF Buy
  • MNMD Strong Buy
  • Analyst Count
  • KREF 6
  • MNMD 10
  • Target Price
  • KREF $12.46
  • MNMD $28.11
  • AVG Volume (30 Days)
  • KREF 490.9K
  • MNMD 3.1M
  • Earning Date
  • KREF 02-03-2025
  • MNMD 03-06-2025
  • Dividend Yield
  • KREF 9.07%
  • MNMD N/A
  • EPS Growth
  • KREF N/A
  • MNMD N/A
  • EPS
  • KREF 0.19
  • MNMD N/A
  • Revenue
  • KREF $100,618,000.00
  • MNMD N/A
  • Revenue This Year
  • KREF N/A
  • MNMD N/A
  • Revenue Next Year
  • KREF $6.81
  • MNMD N/A
  • P/E Ratio
  • KREF $58.51
  • MNMD N/A
  • Revenue Growth
  • KREF 263.33
  • MNMD N/A
  • 52 Week Low
  • KREF $8.71
  • MNMD $4.66
  • 52 Week High
  • KREF $12.95
  • MNMD $12.22
  • Technical
  • Relative Strength Index (RSI)
  • KREF 53.99
  • MNMD 47.18
  • Support Level
  • KREF $11.14
  • MNMD $7.81
  • Resistance Level
  • KREF $11.42
  • MNMD $10.44
  • Average True Range (ATR)
  • KREF 0.27
  • MNMD 1.01
  • MACD
  • KREF 0.04
  • MNMD -0.06
  • Stochastic Oscillator
  • KREF 75.31
  • MNMD 29.07

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

Share on Social Networks: